How Hainan is emerging as China's medical tourism destination

As Hainan continues to optimize its visa-free entry policies for foreign nationals, a growing number of international travelers are incorporating medical check-ups and healthcare services into their itineraries while visiting or attending events on the island. The Boao Lecheng International Medical Tourism Pilot Zone, a special medical area within the Hainan Free Trade Port (FTP), allows overseas visitors to access internationally advanced treatments and innovative medicines without traveling to other countries or regions.

With policy support, healthcare in Hainan is shifting from an emergency-driven service to a more planned form of health consumption. This shift is reflected in the growing use of international medical services by overseas patients, from fast-track consultations and same-day treatment to access to globally approved medicines through special access policies.

At the same time, the island is accelerating the integration of medical services and tourism. Supported by visa-free entry policies for travelers from dozens of countries and regions, Hainan has introduced standardized international clinic systems, including multilingual consultation, one-stop services and direct international insurance settlement. With more than 20 medical institutions now offering international clinics, these improvements are transforming Hainan from a traditional travel destination into an increasingly accessible hub for global healthcare and wellness management.

At the institutional level, the Boao Lecheng International Medical Tourism Pilot Zone has built a policy framework to support cross-border healthcare. Under the FTP, authorities are working to reduce tariffs and value-added taxes on imported drugs and medical devices. The benefits of special access policies allow urgently needed international medicines and technologies to be used on a pilot basis. This approach creates a more open testing ground for global medical innovation, offering international companies faster pathways to validate, adapt and expand their technologies in broader markets.

In terms of resource allocation, the zone continues to attract high-level medical resources. Leading domestic hospitals are encouraged to take part through partnerships in brand, technology and management, while international medical institutions, research platforms and pharmaceutical companies are also brought in, helping build an integrated medical, pharmaceutical and research system that strengthens overall service capacity.

To better serve overseas patients, relevant policies are promoting the development of a full lifecycle healthcare service system covering disease prevention, health management, early screening, precision medicine and rehabilitation. Efforts include improving visa and stay arrangements for foreign patients and their companions, as well as strengthening transport connectivity. Healthcare providers are also establishing multilingual support, direct international insurance settlement and one-stop service systems. Under certain conditions, patients are allowed to take a reasonable amount of imported medication out of the zone for personal use. Supporting services such as health insurance, medical intermediaries and patient navigation platforms are also being developed to lower barriers to cross-border care.

Efforts to internationalize healthcare services are also reflected in policies that facilitate the practice of foreign physicians. Qualified overseas doctors are allowed to work in Boao Lecheng through short-term licensing and institutional partnerships. This helps bring international clinical expertise into the local system while promoting knowledge exchange between domestic and global medical teams. Boao Lecheng continues to attract international healthcare professionals and deepen cooperation with global pharmaceutical companies, particularly as it expands its international medical tourism services.

Boao Lecheng has also attracted a growing number of foreign companies, hospitals and advanced technologies, positioning itself as a global hub for medical innovation. The zone has established partnerships with more than 180 international pharmaceutical and medical device companies from over 20 countries, introducing over 560 innovative products into China while also drawing projects in biomedicine, specialized care and digital health. Supported by an open policy environment, this concentration of global medical resources is accelerating the development of a full lifecycle healthcare service system and enabling companies to use Hainan as a gateway to expand into broader regional and global markets.

Meanwhile, the development model itself is evolving. Boao Lecheng is moving beyond treatment-focused services by integrating digital health, AI and data-driven innovation into its healthcare system. Through models such as "collaborative innovation between medical enterprises, regional special diseases and an integrated platform for digital clinical studies," supported by big data and AI, the zone is accelerating pharmaceutical innovation and enabling full lifecycle management of biopharmaceutical projects. At the same time, it is expanding AI applications in personalized treatment, disease prediction and traditional Chinese medicine, while promoting internet hospitals and health data platforms to deliver continuous, data-driven services from consultation to rehabilitation.

All these efforts are shifting Hainan from a policy-driven platform for introducing drugs and devices to a more innovation-led ecosystem that supports new technologies, business models and global collaboration, strengthening its role as an international hub for medical tourism and healthcare innovation.